Capricor Therapeutics Inc’s recently made public that its 10% Owner Nippon Shinyaku Co Ltd acquired Company’s shares for reported $15.0 million on Sep 20 ’24. In the deal valued at $5.36 per share,2,798,507 shares were bought. As a result of this transaction, Nippon Shinyaku Co Ltd now holds 7,090,351 shares worth roughly $106.36 million.
Piper Sandler initiated its Capricor Therapeutics Inc [CAPR] rating to an Overweight in a research note published on October 21, 2024; the price target was $35. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who began to cover the stock in mid May with a ‘”an Outperform”‘ rating. Cantor Fitzgerald began covering CAPR with “an Overweight” recommendation on January 05, 2024. Ladenburg Thalmann started covering the stock on October 26, 2022. It rated CAPR as “a Buy”.
Price Performance Review of CAPR
On Monday, Capricor Therapeutics Inc [NASDAQ:CAPR] saw its stock fall -3.91% to $15.00. Over the last five days, the stock has gained 6.53%. Capricor Therapeutics Inc shares have risen nearly 8.70% since the year began. Nevertheless, the stocks have risen 183.02% over the past one year. While a 52-week high of $23.40 was reached on 01/03/25, a 52-week low of $3.52 was recorded on 01/02/25. SMA at 50 days reached $16.92, while 200 days put it at $9.37.
Levels Of Support And Resistance For CAPR Stock
The 24-hour chart illustrates a support level at 14.71, which if violated will result in even more drops to 14.43. On the upside, there is a resistance level at 15.54. A further resistance level may holdings at 16.09. The Relative Strength Index (RSI) on the 14-day chart is 50.14, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.26, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 29.85%. Stochastics %K at 84.92% indicates the stock is a selling.
How much short interest is there in Capricor Therapeutics Inc?
A steep rise in short interest was recorded in Capricor Therapeutics Inc stocks on 2024-12-13, growing by 1.75 million shares to a total of 5.59 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 3.85 million shares. There was a rise of 31.23%, which implies that there is a positive sentiment for the stock.
